GC Aesthetics Ltd, one of the world’s leading producers of silicone implants has announced a brand new lifetime warranty on all GC Aesthetics’ breast implants.
With more than 3 million implants sold in the last 10 years and long-term market experience and expertise, GC Aesthetics (GCA) is introducing a brand new lifetime warranty which provides additional coverage to show their commitment to patients and their wellbeing.
The previous GCA Comfort Guarantee provided free of charge implant replacements in the event of rupture or capsular contracture. This coverage will now be enhanced with the new GCA Comfort Plus warranty.
The new warranty continues to provide free of charge implant replacements in the event of rupture or capsular contracture, but also now provides free, automatic and retrospective cover for late seroma (swelling which can occur after breast implant surgery) for products implanted since 1 January 2009.
In addition, in the case of a late seroma it also provides reimbursement of up to $3,000 towards the cost of necessary medical scan(s) and the cost of necessary surgery to remove the breast implant(s) and associated scar tissue.
GC Aesthetics will replace breast implants with any model, size, or style from the significant range of GCA breast implants currently featured in their catalogue.
This warranty improvement sees a significant boost in additional coverage for those with GC Aesthetics’ (Nagor or Eurosilicone) silicone gel-filled breast implants. Furthermore, the improved warranty is also important for plastic surgeons for whom warranty is the most important factor when deciding on the choice of implant to use, according to a recent Global Market Research study conducted by GC Aesthetics.
The GCA Comfort Plus warranty has been launched to reassure patients and surgeons about Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) which is an extremely rare blood cancer. During the last 10 years, there have been no cases of BIA-ALCL with GC Aesthetics’ smooth breast implants and a rate of less than 0.0007% with GC Aesthetics’ textured breast implants.
Although the risks of developing BIA-ALCL in patients with breast implants are very low, GCA wants patients and surgeons to have peace of mind and to feel safe with their products which have been carefully developed by experts in the industry and are backed up by long-term clinical data.
Manuela Schneider-Höfferer, PhD Chief Marketing Officer (CMO), said:
“Our employees are proud about the quality of our implants, our strong clinical data and enduring relationships with our customers and patients. Extending our warranty to a Comfort Plus Warranty signals that we are a real partner for our customers and patients. Safety always comes first and providing confidence to our patients is essential”.
Regarding the importance of the GCA Comfort Plus warranty for both patients and physicians, who will both find reassurance from this update, Manuela commented:
“For more than 40 years, GC Aesthetics has been a reliable partner in the aesthetic surgery business. Every day we work closely with our surgeons and know that BIA-ALCL and the dialogue with their patients around late seroma is not always easy. The Comfort Plus Warranty will help both surgeons and patients to facilitate this communication by providing security, reliability and giving patients peace of mind.”
For more information regarding the GCA Comfort Plus warranty, both existing patients, physicians and those considering silicone implants can visit the GC Aesthetics website for the latest information and updates.
About GC Aesthetics
GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey. Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality silicone breast implants under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. More than 3 million women and men across 70 countries have trusted GCA products, which are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness. The company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.
